Evaluation of Transparency to Improve Good Governance in Pharmaceutical Regulatory Sector of Iran
Background: Improving good governance in the pharmaceutical sector is a valuable priority for improving access to essential medicines. Transparency as a means for good governance was the focus of this study. The objective was to evaluate different sectors of the pharmaceutical regulatory sector of I...
Saved in:
Main Authors: | Yasaman Herandi (Author), Shekoufeh Nikfar (Author), Hossein Bouzarjomehri (Author), Akbar Abdollahiasl (Author) |
---|---|
Format: | Book |
Published: |
Shahid Sadoughi University of Medical Sciences,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Policy of Subsidy Elimination from Currency Allocated to Pharmaceutical Sector in Iran; Concerns of Patients, Payers, and Industry
by: Amir Hashemi, et al.
Published: (2023) -
An evaluation of transparency and accountability in Brazil's pharmaceutical sector
by: M.G. Martinez, et al.
Published: (2016) -
Can a multistakeholder initiative improve transparency and accountability in the pharmaceutical sector? Evidence from the Medicines Transparency Alliance
by: Taryn Vian, PhD, et al.
Published: (2017) -
Satisfaction Level with the Health Transformation Plan in Iran: A Systematic Review
by: Reza Hashempour, et al.
Published: (2021) -
Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran
by: Hadi Abbasian, et al.
Published: (2021)